Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells

Citation
Kr. Lamontagne et al., Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells, AM J PATH, 157(6), 2000, pp. 1937-1945
Citations number
32
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
ISSN journal
00029440 → ACNP
Volume
157
Issue
6
Year of publication
2000
Pages
1937 - 1945
Database
ISI
SICI code
0002-9440(200012)157:6<1937:IOMKKC>2.0.ZU;2-X
Abstract
Activated ras causes increased activity of several signal transduction syst ems, including the mitogen-activated protein kinase kinase (MAPKK) pathway and the phosphoinositol-3-kinase (PI-3-K) pathway. We have previously shown that the PI-3-K pathway plays a major role in regulation of ras-mediated t umor angiogenesis in angiosarcoma cells. However, the contribution of the M APKK pathway to tumorigenesis and angiogenesis is not fully understood. Ove rexpression of constitutively active forms of MAPKK has previously been sho wn to transform nonmalignant MH3T3 fibroblasts, but the effect of down-regu lation of MAPKK on tumorigenesis and angiogenesis in a well established tum or has not been fully explored. We introduced a dominant negative MAPKK gen e into SVR murine angiosarcoma cells. Introduction of a dominant negative M APKK causes a significant decrease in proliferation rate in vitro and morph ological reversion, Cells expressing the dominant negative MAPKK have a gre atly decreased ability to form colonies in soft agar compared with wild-typ e cells. Despite the decreased cell growth in vitro and inability to grow i n soft agar, the cells were equally tumorigenic in nude mice. Our results s uggest that the MAPKK pathway is required for soft agar growth of angiosarc oma cells, and separates the phenotypes of soft agar growth versus in vivo tumorigenicity. These findings have implications in the development of sign al transduction modulators as potential antineoplastic agents.